{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:27:55Z","timestamp":1773365275382,"version":"3.50.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["2021J065"],"award-info":[{"award-number":["2021J065"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11033-022-07487-x","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T20:03:36Z","timestamp":1652904216000},"page":"9813-9824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Kelch-like protein 3 in human disease and therapy"],"prefix":"10.1007","volume":"49","author":[{"given":"Yan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0801-8638","authenticated-orcid":false,"given":"Xiaofeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"7487_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-981-15-0602-4_12","volume":"1206","author":"R Wang","year":"2019","unstructured":"Wang R, Wang G (2019) Protein Modification and Autophagy Activation. Adv Exp Med Biol 1206:237\u2013259. https:\/\/doi.org\/10.1007\/978-981-15-0602-4_12","journal-title":"Adv Exp Med Biol"},{"key":"7487_CR2","doi-asserted-by":"publisher","unstructured":"Faktor J et al (2019) Protein Ubiquitination Research in Oncology. Klin Onkol. 32(Supplementum 3. 56\u201364. https:\/\/doi.org\/10.14735\/amko20193S","DOI":"10.14735\/amko20193S"},{"issue":"1","key":"7487_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrm.2017.83","volume":"19","author":"M Rape","year":"2018","unstructured":"Rape M (2018) Ubiquitylation at the crossroads of development and disease. Nat Rev Mol Cell Biol 19(1):59\u201370. https:\/\/doi.org\/10.1038\/nrm.2017.83","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7487_CR4","doi-asserted-by":"publisher","unstructured":"Nakamura N (2018) Ubiquitin System. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/ijms19041080","DOI":"10.3390\/ijms19041080"},{"key":"7487_CR5","doi-asserted-by":"publisher","unstructured":"Toma-Fukai S, Shimizu T (2021) Structural Diversity of Ubiquitin E3 Ligase. Molecules 26(21). https:\/\/doi.org\/10.3390\/molecules26216682","DOI":"10.3390\/molecules26216682"},{"key":"7487_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semcancer.2020.07.005","volume":"79","author":"MJ Duffy","year":"2022","unstructured":"Duffy MJ et al (2022) Targeting p53 for the treatment of cancer. Semin Cancer Biol 79:58\u201367. https:\/\/doi.org\/10.1016\/j.semcancer.2020.07.005","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"7487_CR7","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41375-020-0949-z","volume":"34","author":"M Konopleva","year":"2020","unstructured":"Konopleva M et al (2020) MDM2 inhibition: an important step forward in cancer therapy. Leukemia 34(11):2858\u20132874. https:\/\/doi.org\/10.1038\/s41375-020-0949-z","journal-title":"Leukemia"},{"key":"7487_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-981-15-1025-0_13","volume":"1217","author":"P Wang","year":"2020","unstructured":"Wang P, Song J, Ye D (2020) CRL3s: The BTB-CUL3-RING E3 Ubiquitin Ligases. Adv Exp Med Biol 1217:211\u2013223. https:\/\/doi.org\/10.1007\/978-981-15-1025-0_13","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"7487_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1479-7364-7-13","volume":"7","author":"BS Dhanoa","year":"2013","unstructured":"Dhanoa BS et al (2013) Update on the Kelch-like (KLHL) gene family. Hum Genomics 7(1):13. https:\/\/doi.org\/10.1186\/1479-7364-7-13","journal-title":"Hum Genomics"},{"key":"7487_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fonc.2012.00200","volume":"2","author":"Y Mitsuishi","year":"2012","unstructured":"Mitsuishi Y, Motohashi H, Yamamoto M (2012) The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front Oncol 2:200. https:\/\/doi.org\/10.3389\/fonc.2012.00200","journal-title":"Front Oncol"},{"issue":"3","key":"7487_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.bbrc.2013.06.104","volume":"437","author":"D Takahashi","year":"2013","unstructured":"Takahashi D et al (2013) KLHL2 interacts with and ubiquitinates WNK kinases. Biochem Biophys Res Commun 437(3):457\u2013462. https:\/\/doi.org\/10.1016\/j.bbrc.2013.06.104","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"7487_CR12","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1073\/pnas.1817281116","volume":"116","author":"K Ishizawa","year":"2019","unstructured":"Ishizawa K et al (2019) Calcineurin dephosphorylates Kelch-like 3, reversing phosphorylation by angiotensin II and regulating renal electrolyte handling. Proc Natl Acad Sci U S A 116(8):3155\u20133160. https:\/\/doi.org\/10.1073\/pnas.1817281116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7487_CR13","doi-asserted-by":"publisher","first-page":"105616","DOI":"10.1016\/j.phrs.2021.105616","volume":"169","author":"S Xiang","year":"2021","unstructured":"Xiang S et al (2021) Targeting Cul3-scaffold E3 ligase complex via KLHL substrate adaptors for cancer therapy. Pharmacol Res 169:105616. https:\/\/doi.org\/10.1016\/j.phrs.2021.105616","journal-title":"Pharmacol Res"},{"issue":"4","key":"7487_CR14","doi-asserted-by":"publisher","first-page":"e","DOI":"10.1371\/journal.pone.0060445","volume":"8","author":"AX Ji","year":"2013","unstructured":"Ji AX, Priv\u00e9 GG (2013) Crystal structure of KLHL3 in complex with Cullin3. PloS one 8(4):e. https:\/\/doi.org\/10.1371\/journal.pone.0060445","journal-title":"PloS one"},{"issue":"7383","key":"7487_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature10814","volume":"482","author":"LM Boyden","year":"2012","unstructured":"Boyden LM et al (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482(7383):98\u2013102. https:\/\/doi.org\/10.1038\/nature10814","journal-title":"Nature"},{"issue":"6","key":"7487_CR16","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.cellsig.2014.01.032","volume":"26","author":"AC Anderica-Romero","year":"2014","unstructured":"Anderica-Romero AC et al (2014) Insights in cullin 3\/WNK4 and its relationship to blood pressure regulation and electrolyte homeostasis. Cell Signal 26(6):1166\u20131172. https:\/\/doi.org\/10.1016\/j.cellsig.2014.01.032","journal-title":"Cell Signal"},{"issue":"1","key":"7487_CR17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3892\/ol.2021.12825","volume":"22","author":"H Zhang","year":"2021","unstructured":"Zhang H et al (2021) LZTR1: A promising adaptor of the CUL3 family. Oncol Lett 22(1):564. https:\/\/doi.org\/10.3892\/ol.2021.12825","journal-title":"Oncol Lett"},{"issue":"16","key":"7487_CR18","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1021\/acs.biochem.9b00066","volume":"58","author":"L Wang","year":"2019","unstructured":"Wang L et al (2019) Unveiling the Distinct Mechanisms by which Disease-Causing Mutations in the Kelch Domain of KLHL3 Disrupt the Interaction with the Acidic Motif of WNK4 through Molecular Dynamics Simulation. Biochemistry 58(16):2105\u20132115. https:\/\/doi.org\/10.1021\/acs.biochem.9b00066","journal-title":"Biochemistry"},{"issue":"3","key":"7487_CR19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1091\/mbc.e06-06-0542","volume":"18","author":"W Wimuttisuk","year":"2007","unstructured":"Wimuttisuk W, Singer JD (2007) The Cullin3 ubiquitin ligase functions as a Nedd8-bound heterodimer. Mol Biol Cell 18(3):899\u2013909. https:\/\/doi.org\/10.1091\/mbc.e06-06-0542","journal-title":"Mol Biol Cell"},{"key":"7487_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.sbi.2020.02.003","volume":"62","author":"ML Rennie","year":"2020","unstructured":"Rennie ML, Chaugule VK, Walden H (2020) Modes of allosteric regulation of the ubiquitination machinery. Curr Opin Struct Biology 62:189\u2013196. https:\/\/doi.org\/10.1016\/j.sbi.2020.02.003","journal-title":"Curr Opin Struct Biology"},{"issue":"8","key":"7487_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41440-020-0437-x","volume":"43","author":"T Furusho","year":"2020","unstructured":"Furusho T, Uchida S, Sohara E (2020) The WNK signaling pathway and salt-sensitive hypertension. Hypertens research: official J Japanese Soc Hypertens 43(8):733\u2013743. https:\/\/doi.org\/10.1038\/s41440-020-0437-x","journal-title":"Hypertens research: official J Japanese Soc Hypertens"},{"issue":"10","key":"7487_CR22","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.15252\/emmm.201505444","volume":"7","author":"FR Schumacher","year":"2015","unstructured":"Schumacher FR et al (2015) Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia. EMBO Mol Med 7(10):1285\u20131306. https:\/\/doi.org\/10.15252\/emmm.201505444","journal-title":"EMBO Mol Med"},{"key":"7487_CR23","doi-asserted-by":"publisher","unstructured":"Murthy M, Kurz T, O\u2019Shaughnessy KM (2016) ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Delta403-459 mutation. Physiol Rep 4. https:\/\/doi.org\/10.14814\/phy2.12850","DOI":"10.14814\/phy2.12850"},{"key":"7487_CR24","doi-asserted-by":"publisher","unstructured":"Fischer S et al (2020) Loss-of-function Mutations of CUL3, a High Confidence Gene for Psychiatric Disorders, Lead to Aberrant Neurodevelopment In Human Induced Pluripotent Stem Cells. Neuroscience. 448: p.\u00a0234\u2013254.https:\/\/doi.org\/10.1016\/j.neuroscience.2020.08.028","DOI":"10.1016\/j.neuroscience.2020.08.028"},{"key":"7487_CR25","doi-asserted-by":"publisher","first-page":"654254","DOI":"10.3389\/fcvm.2021.654254","volume":"8","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jiang G, Zhang C (2021) Downregulation of Cullin 3 Ligase Signaling Pathways Contributes to Hypertension in Preeclampsia. Front Cardiovasc Med 8:654254. https:\/\/doi.org\/10.3389\/fcvm.2021.654254","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"7487_CR26","doi-asserted-by":"publisher","first-page":"F204","DOI":"10.1152\/ajprenal.00497.2019","volume":"318","author":"RJ Cornelius","year":"2020","unstructured":"Cornelius RJ, Yang CL, Ellison DH (2020) Hypertension-causing cullin 3 mutations disrupt COP9 signalosome binding. Am J Physiol Renal Physiol 318(1):F204. https:\/\/doi.org\/10.1152\/ajprenal.00497.2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7513","key":"7487_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nature13566","volume":"512","author":"GM Lingaraju","year":"2014","unstructured":"Lingaraju GM et al (2014) Crystal structure of the human COP9 signalosome. Nature 512(7513):161\u2013165. https:\/\/doi.org\/10.1038\/nature13566","journal-title":"Nature"},{"key":"7487_CR28","doi-asserted-by":"publisher","unstructured":"Louis-Dit-Picard H et al (2012) KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet 44(4) 456 \u2013 60. https:\/\/doi.org\/10.1038\/ng.2218","DOI":"10.1038\/ng.2218"},{"issue":"1","key":"7487_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1042\/BJ20121903","volume":"451","author":"A Ohta","year":"2013","unstructured":"Ohta A et al (2013) The CUL3-KLHL3 E3 ligase complex mutated in Gordon\u2019s hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction. Biochem J 451(1):111\u2013122. https:\/\/doi.org\/10.1042\/BJ20121903","journal-title":"Biochem J"},{"key":"7487_CR30","doi-asserted-by":"publisher","first-page":"104404","DOI":"10.1016\/j.phrs.2019.104404","volume":"148","author":"X Shi","year":"2019","unstructured":"Shi X et al (2019) Kelch-like proteins: Physiological functions and relationships with diseases. Pharmacol Res 148:104404. https:\/\/doi.org\/10.1016\/j.phrs.2019.104404","journal-title":"Pharmacol Res"},{"issue":"2","key":"7487_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bbrc.2015.09.184","volume":"467","author":"Y Yoshizaki","year":"2015","unstructured":"Yoshizaki Y et al (2015) Impaired degradation of WNK by Akt and PKA phosphorylation of KLHL3. Biochem Biophys Res Commun 467(2):229\u2013234. https:\/\/doi.org\/10.1016\/j.bbrc.2015.09.184","journal-title":"Biochem Biophys Res Commun"},{"issue":"43","key":"7487_CR32","doi-asserted-by":"publisher","first-page":"15556","DOI":"10.1073\/pnas.1418342111","volume":"111","author":"S Shibata","year":"2014","unstructured":"Shibata S et al (2014) Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation. Proc Natl Acad Sci U S A 111(43):15556\u201315561. https:\/\/doi.org\/10.1073\/pnas.1418342111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"7487_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/HJH.0b013e32835bbb83","volume":"31","author":"M Ch\u00e1vez-Canales","year":"2013","unstructured":"Ch\u00e1vez-Canales M et al (2013) Insulin increases the functional activity of the renal NaCl cotransporter. J Hypertens 31(2):303\u2013311. https:\/\/doi.org\/10.1097\/HJH.0b013e32835bbb83","journal-title":"J Hypertens"},{"issue":"3","key":"7487_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1515\/jpem-2016-0309","volume":"30","author":"JS Park","year":"2017","unstructured":"Park JS et al (2017) Three cases of Gordon syndrome with dominant KLHL3 mutations. J Pediatr Endocrinol Metab 30(3):361\u2013364. https:\/\/doi.org\/10.1515\/jpem-2016-0309","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"7487_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/BJ20150500","volume":"472","author":"Y Mori","year":"2015","unstructured":"Mori Y et al (2015) Involvement of selective autophagy mediated by p62\/SQSTM1 in KLHL3-dependent WNK4 degradation. Biochem J 472(1):33\u201341. https:\/\/doi.org\/10.1042\/BJ20150500","journal-title":"Biochem J"},{"key":"7487_CR36","doi-asserted-by":"publisher","unstructured":"Mabillard H, Sayer JA (2019) The Molecular Genetics of Gordon Syndrome. Genes (Basel) 10(12). https:\/\/doi.org\/10.3390\/genes10120986","DOI":"10.3390\/genes10120986"},{"key":"7487_CR37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fped.2019.00263","volume":"7","author":"R Raina","year":"2019","unstructured":"Raina R et al (2019) Overview of Monogenic or Mendelian Forms of Hypertension. Front Pediatr 7:263. https:\/\/doi.org\/10.3389\/fped.2019.00263","journal-title":"Front Pediatr"},{"key":"7487_CR38","doi-asserted-by":"publisher","first-page":"111156","DOI":"10.1016\/j.biopha.2020.111156","volume":"134","author":"S Naqvi","year":"2021","unstructured":"Naqvi S et al (2021) A cross-talk between gut microbiome, salt and hypertension. Biomed Pharmacother 134:111156. https:\/\/doi.org\/10.1016\/j.biopha.2020.111156","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"7487_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41569-020-00437-9","volume":"18","author":"PL Valenzuela","year":"2021","unstructured":"Valenzuela PL et al (2021) Lifestyle interventions for the prevention and treatment of hypertension. Nat Rev Cardiol 18(4):251\u2013275. https:\/\/doi.org\/10.1038\/s41569-020-00437-9","journal-title":"Nat Rev Cardiol"},{"key":"7487_CR40","doi-asserted-by":"publisher","unstructured":"Paver WK, Pauline GJ, HYPERTENSION AND HYPERPOTASSAEMIA WITHOUT RENAL DISEASE IN A YOUNG MALE (1964). Med J Aust. 2: p.\u00a0305-6.https:\/\/doi.org\/10.5694\/j.1326-5377.1964.tb115766.x","DOI":"10.5694\/j.1326-5377.1964.tb115766.x"},{"issue":"2","key":"7487_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/boc.201300069","volume":"106","author":"S Uchida","year":"2014","unstructured":"Uchida S et al (2014) Regulation of with-no-lysine kinase signaling by Kelch-like proteins. Biol Cell 106(2):45\u201356. https:\/\/doi.org\/10.1111\/boc.201300069","journal-title":"Biol Cell"},{"key":"7487_CR42","doi-asserted-by":"publisher","unstructured":"O\u2019Shaughnessy KM (2015) Gordon Syndrome: a continuing story. Pediatr Nephrol 30(11). https:\/\/doi.org\/10.1007\/s00467-014-2956-7","DOI":"10.1007\/s00467-014-2956-7"},{"issue":"10","key":"7487_CR43","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/CS20130326","volume":"126","author":"M Glover","year":"2014","unstructured":"Glover M et al (2014) Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon\u2019s syndrome). Clin Sci (Lond) 126(10):721\u2013726. https:\/\/doi.org\/10.1042\/CS20130326","journal-title":"Clin Sci (Lond)"},{"issue":"14","key":"7487_CR44","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1073\/pnas.1421441112","volume":"112","author":"Y Gong","year":"2015","unstructured":"Gong Y et al (2015) KLHL3 regulates paracellular chloride transport in the kidney by ubiquitination of claudin-8. Proc Natl Acad Sci U S A 112(14):4340\u20134345. https:\/\/doi.org\/10.1073\/pnas.1421441112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"7487_CR45","doi-asserted-by":"publisher","first-page":"F216","DOI":"10.1152\/ajprenal.00232.2019","volume":"318","author":"MN Thomson","year":"2019","unstructured":"Thomson MN et al (2019) WNK bodies cluster WNK4 and SPAK\/OSR1 to promote NCC activation in hypokalemia. Am J Physiology-Renal Physiol 318(1):F216. https:\/\/doi.org\/10.1152\/ajprenal.00232.2019","journal-title":"Am J Physiology-Renal Physiol"},{"issue":"2","key":"7487_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.molcel.2011.07.039","volume":"44","author":"G Matsumoto","year":"2011","unstructured":"Matsumoto G et al (2011) Serine 403 phosphorylation of p62\/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell 44(2):279\u2013289. https:\/\/doi.org\/10.1016\/j.molcel.2011.07.039","journal-title":"Mol Cell"},{"issue":"5","key":"7487_CR47","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1681\/ASN.2018070703","volume":"30","author":"K Ishizawa","year":"2019","unstructured":"Ishizawa K et al (2019) Inhibition of Sodium Glucose Cotransporter 2 Attenuates the Dysregulation of Kelch-Like 3 and NaCl Cotransporter in Obese Diabetic Mice. J Am Soc Nephrol 30(5):782\u2013794. https:\/\/doi.org\/10.1681\/ASN.2018070703","journal-title":"J Am Soc Nephrol"},{"key":"7487_CR48","doi-asserted-by":"publisher","unstructured":"Fuladi S et al (2020) Computational Modeling of Claudin Structure and Function. Int J Mol Sci 21(3). https:\/\/doi.org\/10.3390\/ijms21030742","DOI":"10.3390\/ijms21030742"},{"issue":"10","key":"7487_CR49","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1016\/j.ekir.2021.07.025","volume":"6","author":"M Hureaux","year":"2021","unstructured":"Hureaux M et al (2021) The variety of genetic defects explains the phenotypic heterogeneity of Familial Hyperkalemic Hypertension. Kidney Int Rep 6(10):2639\u20132652. https:\/\/doi.org\/10.1016\/j.ekir.2021.07.025","journal-title":"Kidney Int Rep"},{"issue":"2","key":"7487_CR50","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.kint.2020.08.023","volume":"99","author":"MA Anderegg","year":"2021","unstructured":"Anderegg MA et al (2021) The sodium\/proton exchanger NHA2 regulates blood pressure through a WNK4-NCC dependent pathway in the kidney. Kidney Int 99(2):350\u2013363. https:\/\/doi.org\/10.1016\/j.kint.2020.08.023","journal-title":"Kidney Int"},{"issue":"7","key":"7487_CR51","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1681\/asn.2017111155","volume":"29","author":"S Baz\u00faa-Valenti","year":"2018","unstructured":"Baz\u00faa-Valenti S et al (2018) The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway. J Am Soc Nephrol 29(7):1838\u20131848. https:\/\/doi.org\/10.1681\/asn.2017111155","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"7487_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000381563","volume":"130","author":"H Mayan","year":"2015","unstructured":"Mayan H et al (2015) Hypercalciuria in familial hyperkalemia and hypertension with KLHL3 mutations. Nephron 130(1):59\u201365. https:\/\/doi.org\/10.1159\/000381563","journal-title":"Nephron"},{"issue":"1","key":"7487_CR53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00424-016-1906-6","volume":"469","author":"Y Gong","year":"2017","unstructured":"Gong Y, Hou J (2017) Claudins in barrier and transport function-the kidney. Pflugers Arch 469(1):105\u2013113. https:\/\/doi.org\/10.1007\/s00424-016-1906-6","journal-title":"Pflugers Arch"},{"key":"7487_CR54","doi-asserted-by":"publisher","unstructured":"Cornelius RJ et al (2018) Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertension. Am J Physiol Renal Physiol 315(4). https:\/\/doi.org\/10.1152\/ajprenal.00602.2017","DOI":"10.1152\/ajprenal.00602.2017"},{"issue":"11","key":"7487_CR55","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1681\/ASN.2018030333","volume":"29","author":"RJ Cornelius","year":"2018","unstructured":"Cornelius RJ et al (2018) Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway. J Am Soc Nephrol 29(11):2627\u20132640. https:\/\/doi.org\/10.1681\/ASN.2018030333","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"7487_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1161\/HYPERTENSIONAHA.121.17624","volume":"79","author":"HE Chatrathi","year":"2022","unstructured":"Chatrathi HE et al (2022) Novel CUL3 Variant Causing Familial Hyperkalemic Hypertension Impairs Regulation and Function of Ubiquitin Ligase Activity. Hypertension 79(1):60\u201375. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17624","journal-title":"Hypertension"},{"key":"7487_CR57","doi-asserted-by":"publisher","unstructured":"Moreno E et al (2019) Structure-function relationships in the renal NaCl cotransporter (NCC). Curr Top Membr. 83: p.\u00a0177\u2013204.https:\/\/doi.org\/10.1016\/bs.ctm.2019.01.003","DOI":"10.1016\/bs.ctm.2019.01.003"},{"issue":"2","key":"7487_CR58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ (2018) Primary hyperparathyroidism. Nat Rev Endocrinol 14(2):115\u2013125. https:\/\/doi.org\/10.1038\/nrendo.2017.104","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"7487_CR59","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1056\/NEJMcp1714213","volume":"379","author":"KL Insogna","year":"2018","unstructured":"Insogna KL (2018) Primary Hyperparathyroidism. N Engl J Med 379(11):1050\u20131059. https:\/\/doi.org\/10.1056\/NEJMcp1714213","journal-title":"N Engl J Med"},{"key":"7487_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000491034","volume":"51","author":"L Masi","year":"2019","unstructured":"Masi L (2019) Primary Hyperparathyroidism. Front Horm Res 51:1\u201312. https:\/\/doi.org\/10.1159\/000491034","journal-title":"Front Horm Res"},{"issue":"6","key":"7487_CR61","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.beem.2018.09.009","volume":"32","author":"NE Cusano","year":"2018","unstructured":"Cusano NE, Cipriani C, Bilezikian JP (2018) Management of normocalcemic primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 32(6):837\u2013845. https:\/\/doi.org\/10.1016\/j.beem.2018.09.009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"7487_CR62","doi-asserted-by":"publisher","unstructured":"Liu Y et al (2021) Differences in Clinicopathological Characteristics of Papillary Thyroid Carcinoma between Symptomatic and Asymptomatic Patients with Primary Hyperparathyroidism. Int J Endocrinol. 2021: p.\u00a09917694.https:\/\/doi.org\/10.1155\/2021\/9917694","DOI":"10.1155\/2021\/9917694"},{"key":"7487_CR63","doi-asserted-by":"publisher","unstructured":"Li Y, Simonds WF (2016) Endocrine neoplasms in familial syndromes of hyperparathyroidism. Endocrine-related Cancer 23(6). https:\/\/doi.org\/10.1530\/ERC-16-0059. p. R229-R247.","DOI":"10.1530\/ERC-16-0059"},{"issue":"3","key":"7487_CR64","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.beem.2013.05.010","volume":"27","author":"AD Conigrave","year":"2013","unstructured":"Conigrave AD, Ward DT (2013) Calcium-sensing receptor (CaSR): Pharmacological properties and signaling pathways. Best Pract Res Clin Endocrinol Metab 27(3):315\u2013331. https:\/\/doi.org\/10.1016\/j.beem.2013.05.010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"7487_CR65","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/978-3-030-12457-1_41","volume":"1131","author":"S Chavez-Abiega","year":"2020","unstructured":"Chavez-Abiega S et al (2020) Sensing Extracellular Calcium - An Insight into the Structure and Function of the Calcium-Sensing Receptor (CaSR). Adv Exp Med Biol 1131:1031\u20131063. https:\/\/doi.org\/10.1007\/978-3-030-12457-1_41","journal-title":"Adv Exp Med Biol"},{"issue":"37","key":"7487_CR66","doi-asserted-by":"publisher","first-page":"14849","DOI":"10.1073\/pnas.0702810104","volume":"104","author":"H Belge","year":"2007","unstructured":"Belge H et al (2007) Renal expression of parvalbumin is critical for NaCl handling and response to diuretics. Proc Natl Acad Sci U S A 104(37):14849\u201314854. https:\/\/doi.org\/10.1073\/pnas.0702810104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"7487_CR67","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.2215\/CJN.04670510","volume":"5","author":"RF Reilly","year":"2010","unstructured":"Reilly RF, Peixoto AJ, Desir GV (2010) The Evidence-Based Use of Thiazide Diuretics in Hypertension and Nephrolithiasis. Clin J Am Soc Nephrol 5(10):1893. https:\/\/doi.org\/10.2215\/CJN.04670510","journal-title":"Clin J Am Soc Nephrol"},{"key":"7487_CR68","doi-asserted-by":"publisher","unstructured":"Khan SR et al (2016) Kidney stones. Nat Rev Dis Primers 16008. 2https:\/\/doi.org\/10.1038\/nrdp.2016.8","DOI":"10.1038\/nrdp.2016.8"},{"issue":"22","key":"7487_CR69","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","volume":"137","author":"Z Wang","year":"2018","unstructured":"Wang Z et al (2018) Status of Hypertension in China. Circulation 137(22):2344\u20132356. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032380","journal-title":"Circulation"},{"issue":"10112","key":"7487_CR70","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/S0140-6736(17)32478-9","volume":"390","author":"J Lu","year":"2017","unstructured":"Lu J et al (2017) Prevalence, awareness, treatment, and control of hypertension in China: data from 1\u00b77 million adults in a population-based screening study (China PEACE Million Persons Project). The Lancet 390(10112):2549\u20132558. https:\/\/doi.org\/10.1016\/S0140-6736(17)32478-9","journal-title":"The Lancet"},{"issue":"6","key":"7487_CR71","doi-asserted-by":"publisher","first-page":"R297","DOI":"10.1530\/EJE-17-0485","volume":"177","author":"J Pepe","year":"2017","unstructured":"Pepe J et al (2017) Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol 177(6):R297. https:\/\/doi.org\/10.1530\/EJE-17-0485","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"7487_CR72","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","volume":"16","author":"JB Cole","year":"2020","unstructured":"Cole JB, Florez JC (2020) Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol 16(7):377\u2013390. https:\/\/doi.org\/10.1038\/s41581-020-0278-5","journal-title":"Nat Rev Nephrol"},{"key":"7487_CR73","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH et al (2018) IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271\u2013281. https:\/\/doi.org\/10.1016\/j.diabres.2018.02.023","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"7487_CR74","first-page":"103","volume":"93","author":"K Pippitt","year":"2016","unstructured":"Pippitt K, Li M, Gurgle HE (2016) Diabetes Mellitus: Screening and Diagnosis. Am Fam Physician 93(2):103\u2013109","journal-title":"Am Fam Physician"},{"issue":"3","key":"7487_CR75","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1753-0407.2009.00037.x","volume":"1","author":"G Ning","year":"2009","unstructured":"Ning G et al (2009) Progress in diabetes research in China. J Diabetes 1(3):163\u2013172. https:\/\/doi.org\/10.1111\/j.1753-0407.2009.00037.x","journal-title":"J Diabetes"},{"issue":"3","key":"7487_CR76","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.mcna.2016.12.011","volume":"101","author":"M Fayfman","year":"2017","unstructured":"Fayfman M, Pasquel FJ, Umpierrez GE (2017) Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Med Clin North Am 101(3):587\u2013606. https:\/\/doi.org\/10.1016\/j.mcna.2016.12.011","journal-title":"Med Clin North Am"},{"issue":"2","key":"7487_CR77","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00424-020-02509-8","volume":"473","author":"Q Guo","year":"2021","unstructured":"Guo Q et al (2021) Decreased KLHL3 expression is involved in the activation of WNK-OSR1\/SPAK-NCC cascade in type 1 diabetic mice. Pflugers Arch 473(2):185\u2013196. https:\/\/doi.org\/10.1007\/s00424-020-02509-8","journal-title":"Pflugers Arch"},{"issue":"10","key":"7487_CR78","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41580-018-0044-8","volume":"19","author":"Q Yang","year":"2018","unstructured":"Yang Q, Vijayakumar A, Kahn BB (2018) Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol 19(10):654\u2013672. https:\/\/doi.org\/10.1038\/s41580-018-0044-8","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"7487_CR79","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JAD-161250","volume":"57","author":"W Li","year":"2017","unstructured":"Li W, Huang E, Gao S (2017) Type 1 Diabetes Mellitus and Cognitive Impairments: A Systematic Review. J Alzheimers Dis 57(1):29\u201336. https:\/\/doi.org\/10.3233\/JAD-161250","journal-title":"J Alzheimers Dis"},{"key":"7487_CR80","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"A Katsarou","year":"2017","unstructured":"Katsarou A et al (2017) Type 1 diabetes mellitus. Nat Rev Dis Primers 3:17016. https:\/\/doi.org\/10.1038\/nrdp.2017.16","journal-title":"Nat Rev Dis Primers"},{"key":"7487_CR81","doi-asserted-by":"publisher","first-page":"109000","DOI":"10.1016\/j.abb.2021.109000","volume":"710","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021) Dysfunction of Cullin 3 RING E3 ubiquitin ligase causes vasoconstriction and increased sodium reabsorption in diabetes. Arch Biochem Biophys 710:109000. https:\/\/doi.org\/10.1016\/j.abb.2021.109000","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"7487_CR82","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12519-011-0326-0","volume":"7","author":"L Dai","year":"2011","unstructured":"Dai L et al (2011) Birth defects surveillance in China. World J Pediatr 7(4):302\u2013310. https:\/\/doi.org\/10.1007\/s12519-011-0326-0","journal-title":"World J Pediatr"},{"issue":"7","key":"7487_CR83","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10654-020-00653-0","volume":"35","author":"L Zhao","year":"2020","unstructured":"Zhao L et al (2020) Birth prevalence of congenital heart disease in China, 1980\u20132019: a systematic review and meta-analysis of 617 studies. Eur J Epidemiol 35(7):631\u2013642. https:\/\/doi.org\/10.1007\/s10654-020-00653-0","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"7487_CR84","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/ije\/dyz009","volume":"48","author":"Y Liu","year":"2019","unstructured":"Liu Y et al (2019) Global birth prevalence of congenital heart defects 1970\u20132017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol 48(2):455\u2013463. https:\/\/doi.org\/10.1093\/ije\/dyz009","journal-title":"Int J Epidemiol"},{"issue":"14","key":"7487_CR85","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/cvr\/cvz111","volume":"115","author":"DWD Kuster","year":"2019","unstructured":"Kuster DWD et al (2019) Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy. Cardiovasc Res 115(14):1986\u20131997. https:\/\/doi.org\/10.1093\/cvr\/cvz111","journal-title":"Cardiovasc Res"},{"issue":"1","key":"7487_CR86","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yexcr.2017.03.025","volume":"355","author":"L Wang","year":"2017","unstructured":"Wang L et al (2017) cMyBP-C was decreased via KLHL3-mediated proteasomal degradation in congenital heart diseases. Exp Cell Res 355(1):18\u201325. https:\/\/doi.org\/10.1016\/j.yexcr.2017.03.025","journal-title":"Exp Cell Res"},{"issue":"15","key":"7487_CR87","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1080\/14767058.2019.1633300","volume":"33","author":"N Sahin-Uysal","year":"2020","unstructured":"Sahin-Uysal N et al (2020) Maternal and cord blood homocysteine, vitamin B12, folate, and B-type natriuretic peptide levels at term for predicting congenital heart disease of the neonate: A case-control study. J Matern Fetal Neonatal Med 33(15):2649\u20132656. https:\/\/doi.org\/10.1080\/14767058.2019.1633300","journal-title":"J Matern Fetal Neonatal Med"},{"key":"7487_CR88","doi-asserted-by":"publisher","first-page":"108255","DOI":"10.1016\/j.abb.2020.108255","volume":"681","author":"S San Juan-Reyes","year":"2020","unstructured":"San Juan-Reyes S et al (2020) Oxidative stress in pregnancy complicated by preeclampsia. Arch Biochem Biophys 681:108255. https:\/\/doi.org\/10.1016\/j.abb.2020.108255","journal-title":"Arch Biochem Biophys"},{"issue":"Suppl 1","key":"7487_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"LC Poon","year":"2019","unstructured":"Poon LC et al (2019) The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet 145(Suppl 1):1\u201333. https:\/\/doi.org\/10.1002\/ijgo.12802","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"7487_CR90","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.prp.2017.10.021","volume":"214","author":"FR Helmo","year":"2018","unstructured":"Helmo FR et al (2018) Angiogenic and antiangiogenic factors in preeclampsia. Pathol Res Pract 214(1):7\u201314. https:\/\/doi.org\/10.1016\/j.prp.2017.10.021","journal-title":"Pathol Res Pract"},{"issue":"2","key":"7487_CR91","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/mnh.0000000000000579","volume":"29","author":"S Fang","year":"2020","unstructured":"Fang S, Sigmund CD (2020) PPAR\u03b3 and RhoBTB1 in hypertension. Curr Opin Nephrol Hypertens 29(2):161\u2013170. https:\/\/doi.org\/10.1097\/mnh.0000000000000579","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"7487_CR92","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cmet.2012.08.011","volume":"16","author":"CJ Pelham","year":"2012","unstructured":"Pelham CJ et al (2012) Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPAR\u03b3 and RhoA\/Rho-kinase. Cell Metab 16(4):462\u2013472. https:\/\/doi.org\/10.1016\/j.cmet.2012.08.011","journal-title":"Cell Metab"},{"issue":"5","key":"7487_CR93","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.apsb.2020.09.009","volume":"11","author":"NF Meor Azlan","year":"2021","unstructured":"Meor Azlan NF, Koeners MP, Zhang J (2021) Regulatory control of the Na-Cl co-transporter NCC and its therapeutic potential for hypertension. Acta Pharm Sin B 11(5):1117\u20131128. https:\/\/doi.org\/10.1016\/j.apsb.2020.09.009","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"7487_CR94","doi-asserted-by":"publisher","first-page":"F300","DOI":"10.1152\/ajprenal.00441.2009","volume":"299","author":"B Ko","year":"2010","unstructured":"Ko B et al (2010) RasGRP1 stimulation enhances ubiquitination and endocytosis of the sodium-chloride cotransporter. Am J Physiol Renal Physiol 299(2):F300. https:\/\/doi.org\/10.1152\/ajprenal.00441.2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"7487_CR95","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41375-019-0661-z","volume":"34","author":"X Jin","year":"2020","unstructured":"Jin X et al (2020) CRL3-SPOP ubiquitin ligase complex suppresses the growth of diffuse large B-cell lymphoma by negatively regulating the MyD88\/NF-kappaB signaling. Leukemia 34(5):1305\u20131314. https:\/\/doi.org\/10.1038\/s41375-019-0661-z","journal-title":"Leukemia"},{"issue":"6","key":"7487_CR96","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s43018-020-0071-1","volume":"1","author":"R Romero","year":"2020","unstructured":"Romero R et al (2020) Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1. Nat Cancer 1(6):589\u2013602. https:\/\/doi.org\/10.1038\/s43018-020-0071-1","journal-title":"Nat Cancer"},{"issue":"10229","key":"7487_CR97","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/s0140-6736(20)30164-1","volume":"395","author":"PL Bedard","year":"2020","unstructured":"Bedard PL et al (2020) Small molecules, big impact: 20 years of targeted therapy in oncology. Lancet 395(10229):1078\u20131088. https:\/\/doi.org\/10.1016\/s0140-6736(20)30164-1","journal-title":"Lancet"},{"issue":"1","key":"7487_CR98","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1096\/fj.201801023R","volume":"33","author":"CM Lin","year":"2019","unstructured":"Lin CM et al (2019) Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain. FASEB J 33(1):1051\u20131061. https:\/\/doi.org\/10.1096\/fj.201801023R","journal-title":"FASEB J"},{"issue":"2","key":"7487_CR99","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/pro.3063","volume":"26","author":"L Wang","year":"2017","unstructured":"Wang L, Peng JB (2017) Phosphorylation of KLHL3 at serine 433 impairs its interaction with the acidic motif of WNK4: a molecular dynamics study. Protein Sci 26(2):163\u2013173. https:\/\/doi.org\/10.1002\/pro.3063","journal-title":"Protein Sci"},{"issue":"1","key":"7487_CR100","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000475825","volume":"137","author":"O Kliuk-Ben Bassat","year":"2017","unstructured":"Kliuk-Ben Bassat O et al (2017) Familial Hyperkalemia and Hypertension (FHHt) and KLHL3: Description of a Family with a New Recessive Mutation (S553L) Compared to a Family with a Dominant Mutation, Q309R, with Analysis of Urinary Sodium Chloride Cotransporter. Nephron 137(1):77\u201384. https:\/\/doi.org\/10.1159\/000475825","journal-title":"Nephron"},{"issue":"11","key":"7487_CR101","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1177\/0009922820920938","volume":"59","author":"D Doan","year":"2020","unstructured":"Doan D et al (2020) Novel KLHL3 Variant in an Infant With Gordon Syndrome. Clin Pediatr (Phila) 59(11):1011\u20131013. https:\/\/doi.org\/10.1177\/0009922820920938","journal-title":"Clin Pediatr (Phila)"},{"key":"7487_CR102","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-021-01083-1","author":"F Anglani","year":"2021","unstructured":"Anglani F et al (2021) Genotype-phenotype correlation in Gordon\u2019s syndrome: report of two cases carrying novel heterozygous mutations. J Nephrol. https:\/\/doi.org\/10.1007\/s40620-021-01083-1","journal-title":"J Nephrol"},{"issue":"3","key":"7487_CR103","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/ajh\/hpz185","volume":"33","author":"M Ostrosky-Frid","year":"2020","unstructured":"Ostrosky-Frid M et al (2020) Familial Hyperkalemic Hypertension Genotype With a Negative Phenotype: A CUL3 Mosaicism. Am J Hypertens 33(3):278\u2013281. https:\/\/doi.org\/10.1093\/ajh\/hpz185","journal-title":"Am J Hypertens"},{"issue":"3","key":"7487_CR104","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/2211-5463.12389","volume":"8","author":"L Shao","year":"2018","unstructured":"Shao L et al (2018) A novel mutation in exon 9 of Cullin 3 gene contributes to aberrant splicing in pseudohypoaldosteronism type II. FEBS Open Bio 8(3):461\u2013469. https:\/\/doi.org\/10.1002\/2211-5463.12389","journal-title":"FEBS Open Bio"},{"issue":"11","key":"7487_CR105","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/nep.13752","volume":"25","author":"K Nakano","year":"2020","unstructured":"Nakano K et al (2020) Familial cases of pseudohypoaldosteronism type II harboring a novel mutation in the Cullin 3 gene. Nephrol (Carlton) 25(11):818\u2013821. https:\/\/doi.org\/10.1111\/nep.13752","journal-title":"Nephrol (Carlton)"},{"issue":"3","key":"7487_CR106","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00467-019-04352-1","volume":"35","author":"Z Yavas Abali","year":"2020","unstructured":"Yavas Abali Z et al (2020) Rare cause of severe hypertension in an adolescent boy presenting with short stature: Answers. Pediatr Nephrol 35(3):405\u2013407. https:\/\/doi.org\/10.1007\/s00467-019-04352-1","journal-title":"Pediatr Nephrol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07487-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07487-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07487-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T11:46:04Z","timestamp":1664279164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07487-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":106,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["7487"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07487-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}